Walleye Capital
GRTS

Walleye Capital’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Walleye Capital’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12,000
Closed -$24.5K – 6032
2023
Q4 		$24.5K Buy
+12,000
New +$21.9K ﹤0.01% 4442
2021
Q2 		– Sell
-69,257
Closed -$653 – 1547
2021
Q1 		$653 Sell
69,257
-37,431
-35% -$516K 0.04% 466
2020
Q4 		$420 Sell
106,688
-65,390
-38% -$198K 0.03% 530
2020
Q3 		$456K Buy
+172,078
New +$639K 0.05% 410
2018
Q3 		$7K Buy
+473
New +$6.74K ﹤0.01% 307

Other funds holding GRTS

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Walleye Capital's GRTS Position: Q1 2024 in Review

Walleye Capital sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q1 2024, closing a stake of 12,000 shares — an estimated $24.5K sold.

Walleye Capital first reported a position in GRTS in Q3 2018 and held it in 5 quarters. The position peaked at $456K in Q3 2020. 85 funds tracked by Wall St. Rank hold GRTS as of Q1 2024.

  • Walleye Capital reported no remaining Gritstone bio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Walleye Capital sold 12,000 Gritstone bio, Inc. Common Stock shares in Q1 2024, an estimated $24.5K.
  • Walleye Capital first reported a position in Gritstone bio, Inc. Common Stock in Q3 2018 and held it in 5 quarters.
  • Walleye Capital's Gritstone bio, Inc. Common Stock position peaked at $456K in Q3 2020.
  • 85 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q1 2024.

Based on Walleye Capital's 13F filing for Q1 2024, filed 15 May 2024.